Listed by the USPTO as ZIEGLER, ABIGAIL M
Tech Center 3700 • Art Units: 3794
This examiner grants 47% of resolved cases
ZIEGLER, ABIGAIL M works in Tech Center 3700 and Art Unit 3794. The profile includes 110 resolved cases and an allowance rate of 47.3%. The median time to allowance is 1475 days, indicating that applicants should plan for extended prosecution and preserve flexibility around related rights.
The interview lift is 46.7%, a substantial association with allowance outcomes in the available record. Interview preparation may deserve significant attention, especially where claim scope or technical distinctions require direct explanation. The represented companies include Biosense Webster (Israel) Ltd., Boston Scientific Corporation, and Abbott Laboratories. The listed firms are Troutman Pepper Locke LLP, FISH & RICHARDSON P.C. (TC), and SEAGER, TUFTE & WICKHEM, LLP.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19081488 | SYSTEMS AND METHODS FOR CONTROLLING ARCING | Non-Final OA | Covidien LP |
| 19053074 | TISSUE ABLATION USING A MEDICAL DEVICE | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 17746236 | Energy Delivery System, Method and Device | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 17652715 | SYSTEMS, APPARATUSES, AND METHODS FOR VAPOR GENERATION | Final Rejection | Boston Scientific Scimed, Inc. |
| 16999790 | SYSTEMS, APPARATUSES, AND METHODS FOR TISSUE ABLATION | Non-Final OA | Boston Scientific Scimed, Inc. |
| 19049646 | HIGH FREQUENCY VASCULAR CLOSURE DEVICE | Non-Final OA | TERUMO MEDICAL CORPORATION |
| 18720963 | NEUROMODULATION CATHETER | Final Rejection | Medtronic Ireland Manufacturing Unlimited Company |
| 19005961 | MAPPING CATHETER WITH FLEX PANEL ELECTRODE ASSEMBLY | Non-Final OA | BIOSENSE WEBSTER (ISRAEL) LTD. |
| 18822984 | PCB CABLE ASSEMBLY FOR A CATHETER | Non-Final OA | BIOSENSE WEBSTER (ISRAEL) LTD. |
| 18544835 | MAPPING AND ABLATION CATHETER | Final Rejection | Biosense Webster (Israel) Ltd. |
| 18500285 | DEFORMED SPINE ELECTRODE BASKET AND METHODS OF THE SAME | Non-Final OA | Biosense Webster (Israel) Ltd. |
| 18065994 | SYSTEMS AND METHODS FOR LINEAR SPINES AND SPINE RETENTION HUB FOR IMPROVED TISSUE CONTACT AND CURRENT DELIVERY | Final Rejection | Biosense Webster (Israel) Ltd. |
| 18065876 | SYSTEMS AND METHODS FOR C-SHAPED SPINES FORMING A SPHERICAL BASKET FOR IMPROVED TISSUE CONTACT AND CURRENT DELIVERY | Final Rejection | Biosense Webster (Israel) Ltd. |
| 18805400 | SYSTEMS AND METHODS FOR TISSUE ABLATION AND MEASUREMENTS RELATING TO THE SAME | Final Rejection | Hepta Medical SAS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy47.3% of resolved applications examined by Abigail M Ziegler were allowed (110 resolved cases), compared with 60.1% across Art Unit 3794 over the last five years.
This examiner's interview lift is +46.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Abigail M Ziegler took 1,475 days on average from filing to allowance.
Abigail M Ziegler examines applications in Art Unit 3794 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
